Renin System Responses to Combined Renin Inhibition and Beta Adrenergic Blockade

Trial Profile

Renin System Responses to Combined Renin Inhibition and Beta Adrenergic Blockade

Discontinued
Phase of Trial: Phase II

Latest Information Update: 26 Nov 2015

At a glance

  • Drugs Aliskiren (Primary) ; Metoprolol
  • Indications Essential hypertension
  • Focus Pharmacodynamics
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 12 Jul 2011 Planned end date changed from 1 Mar 2012 to 1 May 2010 as reported by ClinicalTrials.gov.
    • 04 Jun 2010 Status changed from recruiting to discontinued.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top